Surgery Partners, Inc. (SGRY) Misses Q2 EPS by 27c, Miss on Revenues; Offers FY17 Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to Surgery Partners, Inc. (SGRY) Misses Q2 EPS by 27c, Miss on Revenues; Offers FY17 Revenues
August 9, 2017 3:52 AM EDT
Raymond James downgraded Surgery Partners (NASDAQ: SGRY) from Strong Buy to Market Perform.
For an analyst ratings summary and ratings history on Surgery Partners click here. For more ratings news on Surgery Partners click here.
Shares of Surgery Partners closed at $19.15 yesterday.
...
More
August 9, 2017 3:46 AM EDT
Stifel downgraded Surgery Partners (NASDAQ: SGRY) from Hold to Sell with a price target of $17.00 (from $21.00).
Analyst Chris Vanacore expects NT pressure on the product mix and sees operating expenses constraining growth. The analyst also discussed his disappointment with guidance and... More
August 9, 2017 3:45 AM EDT
KeyBanc downgraded Surgery Partners (NASDAQ: SGRY) from Overweight to Sector Weight.
For an analyst ratings summary and ratings history on Surgery Partners click here. For more ratings news on Surgery Partners click here.
Shares of Surgery Partners closed at $19.15 yesterday.
...
More
